-
-
-
Treatment of Recent-Onset AF with the Pill-in-the-Pocket; Antibody Responses after Intradermal Flu Vaccination; Isosorbide Dinitrate and Hydralazine in HF; Acetyl-L-Carnitine Improves Pain, Nerve Regeneration, and Vibratory Perception; Levodopa and the Progression of Parkinsons Disease; Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 years after Bariatric Surgery.
-
The Food and Drug Administration (FDA) has strengthened the warning information on the labeling for the abortion drug mifepristone. The labeling change is in response to reports of infection, bleeding, and death among women who have taken the drug, according to the FDA.
-
The next patient in your exam room is an adolescent female, who says shes interested in birth control pills. Her chief focus? While shes interested in contraception, she asks several questions about an acne pill.
-
Efforts to lower the rates of gonorrhea in the United States are dipping figures to all-time lows, but work remains to erase racial disparities and combat growing drug resistance to the sexually transmitted disease (STD).
-
What are some emerging trends in other sexually transmitted diseases (STDs) in the United States? Check the following highlights from the Atlanta-based Centers for Disease Control and Preventions (CDC) 2003 STD Surveillance Report.
-
Just-released information from the National Survey of Family Growth offers family planning clinicians a mix of good and bad news: While sexually active teens are more likely to be using contraception, many teens are uninformed about birth control choices.
-
If it were easier for women to obtain emergency contraception (EC), would it result in an increase in unprotected intercourse, cause women to forego their current method of contraception, or increase the risk of sexually transmitted diseases (STDs)? Apparently not, according to the findings of a just-published study.
-
How many women do you see in your practice who say they have chronic or recurrent headaches? If the numbers are high, dont be surprised: Headaches are a frequent occurrence in women of reproductive age. But what is your approach in determining whether these women may use combined oral contraceptives (OCs)?
